Annual report pursuant to Section 13 and 15(d)

Earnings (Loss) Per Common Share (Details)

v3.5.0.2
Earnings (Loss) Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Basic and diluted numerator:    
Net loss available to iBio, Inc. stockholders $ (9,764) $ (6,625)
Basic and diluted denominator:    
Weighted-average common shares outstanding 80,973 71,495
Per share amount $ (0.12) $ (0.09)